The level of inflammatory markers in patients with myocardial infarction after percutaneous coronary intervention

Cardiovascular diseases are among the most widespread diseases in the world that affect all ages and sometimes can lead to death. Atherosclerosis, coronary syndrome and myocardial infarction are usually associated with artery occlusion and require percutaneous coronary intervention (PCI) as a non-su...

Full description

Saved in:
Bibliographic Details
Main Authors: Hadeel S. Abd-Alwahab, Bayadir Abdul Hussein Mahmeed, Nesreen Ahmed Nasser, Osama A. Mohsein
Format: Article
Language:English
Published: National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry 2024-08-01
Series:The Ukrainian Biochemical Journal
Subjects:
Online Access:http://ukrbiochemjournal.org/wp-content/uploads/2024/07/Abd-Alwahab_96_4.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850275689887956992
author Hadeel S. Abd-Alwahab
Bayadir Abdul Hussein Mahmeed
Nesreen Ahmed Nasser
Osama A. Mohsein
author_facet Hadeel S. Abd-Alwahab
Bayadir Abdul Hussein Mahmeed
Nesreen Ahmed Nasser
Osama A. Mohsein
author_sort Hadeel S. Abd-Alwahab
collection DOAJ
description Cardiovascular diseases are among the most widespread diseases in the world that affect all ages and sometimes can lead to death. Atherosclerosis, coronary syndrome and myocardial infarction are usually associated with artery occlusion and require percutaneous coronary intervention (PCI) as a non-surgical procedure to restore blood flow to the heart. Inflammatory biomarkers, especially interleukins and cardiac biomarkers, have an important role in diagnosing the state of patients with heart damage. The goal of the study was to estimate the serum levels of interleukins and cardiac biomarkers after PCI to reduce the risk of acute coronary syndrome. The study included 100 persons between the ages of 40 and 69 diagnosed with acute coronary syndrome who had successful PCI and a control group consisting of 50 healthy participants of the same age. The levels of interleukins, сreatine kinase MB and myoglobin were measured using an enzyme-linked immunosorbent assay. Troponin and D-dimer levels were measured using immunoassay. It was found that patients before PCI had significantly higher levels of IL-1β, IL-6, IL-8, cardiac troponin I, D-dimer, creatine kinase-MB and myoglobin compared to the control group. One day after PCI, the levels of IL -6, IL-8, cardiac troponin I and D-dimer remained elevated. One week after PCI, the levels of IL-1β, IL-6, IL-8, CK-MB and myoglobin did not show significant differences compared to the control group, while the levels of cardiac troponin I and D-dimer remained higher. Results obtained indicate that in patients after PCI, the levels of interleukins decreased, indicating the reduction of inflammatory processes, but cardiac damage persists to a certain degree, even a week after PCI.
format Article
id doaj-art-99173f386bb44082aa96d54048c5ff97
institution OA Journals
issn 2409-4943
2413-5003
language English
publishDate 2024-08-01
publisher National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry
record_format Article
series The Ukrainian Biochemical Journal
spelling doaj-art-99173f386bb44082aa96d54048c5ff972025-08-20T01:50:38ZengNational Academy of Sciences of Ukraine, Palladin Institute of BiochemistryThe Ukrainian Biochemical Journal2409-49432413-50032024-08-01964445410.15407/ubj96.04.044The level of inflammatory markers in patients with myocardial infarction after percutaneous coronary interventionHadeel S. Abd-Alwahab0https://orcid.org/0000-0003-3463-213XBayadir Abdul Hussein Mahmeed1Nesreen Ahmed Nasser2https://orcid.org/0000-0003-3047-9967Osama A. Mohsein3https://orcid.org/0009-0004-5628-2382College of Medicine, Al-Nahrain University, Baghdad, IraqCollege of Medicine, Al-Nahrain University, Baghdad, IraqCollege of Medicine, Al-Nahrain University, Baghdad, IraqMain Laboratory Unit, Al Habbobi Teaching Hospital, Thi-Qar Health Directorate, Thi-Qar, Iraq; Department of Medical Laboratory Techniques, Mazaya University College, Thi-Qar, IraqCardiovascular diseases are among the most widespread diseases in the world that affect all ages and sometimes can lead to death. Atherosclerosis, coronary syndrome and myocardial infarction are usually associated with artery occlusion and require percutaneous coronary intervention (PCI) as a non-surgical procedure to restore blood flow to the heart. Inflammatory biomarkers, especially interleukins and cardiac biomarkers, have an important role in diagnosing the state of patients with heart damage. The goal of the study was to estimate the serum levels of interleukins and cardiac biomarkers after PCI to reduce the risk of acute coronary syndrome. The study included 100 persons between the ages of 40 and 69 diagnosed with acute coronary syndrome who had successful PCI and a control group consisting of 50 healthy participants of the same age. The levels of interleukins, сreatine kinase MB and myoglobin were measured using an enzyme-linked immunosorbent assay. Troponin and D-dimer levels were measured using immunoassay. It was found that patients before PCI had significantly higher levels of IL-1β, IL-6, IL-8, cardiac troponin I, D-dimer, creatine kinase-MB and myoglobin compared to the control group. One day after PCI, the levels of IL -6, IL-8, cardiac troponin I and D-dimer remained elevated. One week after PCI, the levels of IL-1β, IL-6, IL-8, CK-MB and myoglobin did not show significant differences compared to the control group, while the levels of cardiac troponin I and D-dimer remained higher. Results obtained indicate that in patients after PCI, the levels of interleukins decreased, indicating the reduction of inflammatory processes, but cardiac damage persists to a certain degree, even a week after PCI.http://ukrbiochemjournal.org/wp-content/uploads/2024/07/Abd-Alwahab_96_4.pdfcreatine kinase mbd-dimerinterleukinmyocardial infarctionmyoglobinpercutaneous coronary intervention
spellingShingle Hadeel S. Abd-Alwahab
Bayadir Abdul Hussein Mahmeed
Nesreen Ahmed Nasser
Osama A. Mohsein
The level of inflammatory markers in patients with myocardial infarction after percutaneous coronary intervention
The Ukrainian Biochemical Journal
creatine kinase mb
d-dimer
interleukin
myocardial infarction
myoglobin
percutaneous coronary intervention
title The level of inflammatory markers in patients with myocardial infarction after percutaneous coronary intervention
title_full The level of inflammatory markers in patients with myocardial infarction after percutaneous coronary intervention
title_fullStr The level of inflammatory markers in patients with myocardial infarction after percutaneous coronary intervention
title_full_unstemmed The level of inflammatory markers in patients with myocardial infarction after percutaneous coronary intervention
title_short The level of inflammatory markers in patients with myocardial infarction after percutaneous coronary intervention
title_sort level of inflammatory markers in patients with myocardial infarction after percutaneous coronary intervention
topic creatine kinase mb
d-dimer
interleukin
myocardial infarction
myoglobin
percutaneous coronary intervention
url http://ukrbiochemjournal.org/wp-content/uploads/2024/07/Abd-Alwahab_96_4.pdf
work_keys_str_mv AT hadeelsabdalwahab thelevelofinflammatorymarkersinpatientswithmyocardialinfarctionafterpercutaneouscoronaryintervention
AT bayadirabdulhusseinmahmeed thelevelofinflammatorymarkersinpatientswithmyocardialinfarctionafterpercutaneouscoronaryintervention
AT nesreenahmednasser thelevelofinflammatorymarkersinpatientswithmyocardialinfarctionafterpercutaneouscoronaryintervention
AT osamaamohsein thelevelofinflammatorymarkersinpatientswithmyocardialinfarctionafterpercutaneouscoronaryintervention
AT hadeelsabdalwahab levelofinflammatorymarkersinpatientswithmyocardialinfarctionafterpercutaneouscoronaryintervention
AT bayadirabdulhusseinmahmeed levelofinflammatorymarkersinpatientswithmyocardialinfarctionafterpercutaneouscoronaryintervention
AT nesreenahmednasser levelofinflammatorymarkersinpatientswithmyocardialinfarctionafterpercutaneouscoronaryintervention
AT osamaamohsein levelofinflammatorymarkersinpatientswithmyocardialinfarctionafterpercutaneouscoronaryintervention